WHO to Endorse Triple-Dose Anti-HIV Generics

Law360, New York (October 25, 2003, 12:00 AM EDT) -- The World Health Organization will disclose its global strategy to bring down AIDS drug costs next week and will endorse generic triple-dose HIV drugs, the Washington Post reported on Saturday.

The endorsement is seen as controversial, since a distribution of generic drugs could violate a variety of patents, according to the newspaper.

One generic combination drug is already is being sold by an Indian company, and several others are in the pipeline, the newspaper reported.

WHO officials and AIDS groups have been negotiating with the companies...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.